CLL11: A Study of Rituximab With Chlorambucil or Chlorambucil Alone in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1b)
Clinical trial NCT01998880 · COMPLETED
Trial details
- NCT number
- NCT01998880
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-22
- Primary completion
- 2012-08-01
- Enrollment
- 787
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.